← Evidence map

ArticleBMC cancer2025

Optimal qMSP cutoff value for MGMT promoter methylation in glioblastoma and its validation for clinical significance.

Zeynep Huseyinoglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41316075